Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Inovio Pharmaceuticals Inc New INO

Healthcare Biotechnology
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA... see more

Current News (NDAQ:INO)

Pomerantz LLP Initiates Class Action Lawsuit Against Inovio Pharmaceuticals, Inc.  - INO

ACCESS Newswire 2 hours ago

INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

Newsfile 5 hours ago

INO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

ACCESS Newswire 6 hours ago

Pomerantz LLP Initiates Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. - INO

ACCESS Newswire 19 hours ago

Pomerantz LLP Initiates Class Action Against Inovio Pharmaceuticals, Inc.  - INO

ACCESS Newswire 1 day ago

Pomerantz LLP Initiates Class Action Against Inovio Pharmaceuticals, Inc. - INO

ACCESS Newswire 1 day ago

Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

GlobeNewswire 2 days ago

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire 2 days ago

INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

GlobeNewswire 2 days ago
View More News ››

Opinion & Analysis (NDAQ:INO)

Acceleration of COVID-19 Vaccine Programs Could Benefit U.S. Biotech

Streetwise Reports May 14, 2020

Inovio Pharma Awarded $9M Development Grant for Coronavirus Vaccine

Streetwise Reports January 28, 2020

Coverage Initiated on Immunotherapies Developer with 'Catalyst Rich 2020'

Streetwise Reports December 27, 2019

Immuno-oncology Firm to Co-Develop Companion Diagnostic for Cervical Dysplasia

Streetwise Reports May 27, 2019

Immunotherapeutic Agent Shows Efficacy in Rare Respiratory Disease

Streetwise Reports April 11, 2019

After Financing Close, Biotech's Subsidiary to Operate Independently

Streetwise Reports March 6, 2019
View More Opinion ››

Bullboard Posts (NDAQ:INO)

Nobody cares about this stock anymore

Anything they say will cause the sp to go down. Discouraging to be a bag holder for so long
FLYIN - March 12, 2025

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
JayDestura - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
JayDestura - July 13, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
JayDestura - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
JayDestura - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
JayDestura - May 10, 2022
View more Bullboard ››

Specificity Inc.

Specificity Inc.

Specificity, Inc. operates as a digital marketing company in the United States and internationally. It offers Tradigital ...
View More »

Podcasts